Sequencing by Expansion

Information

  • Research Project
  • 8183403
  • ApplicationId
    8183403
  • Core Project Number
    R21HG006304
  • Full Project Number
    1R21HG006304-01
  • Serial Number
    6304
  • FOA Number
    RFA-HG-10-013
  • Sub Project Id
  • Project Start Date
    8/15/2011 - 13 years ago
  • Project End Date
    7/31/2013 - 11 years ago
  • Program Officer Name
    SCHLOSS, JEFFERY
  • Budget Start Date
    8/15/2011 - 13 years ago
  • Budget End Date
    7/31/2012 - 12 years ago
  • Fiscal Year
    2011
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/12/2011 - 13 years ago
Organizations

Sequencing by Expansion

DESCRIPTION (provided by applicant): DNA expansion is a highly desired process that may benefit and enable several next generation DNA sequencing approaches;however, a practical and inexpensive DNA expansion process is currently not available. DNA expansion is a physical process in which the information of single nucleotides is translated into a much larger and easily readable structure (called a reporter). Nanopores are ideal readers for the proposed expanded constructs (called Xpandomers). In this proposal, Stratos Genomics and the University of Washington are merging strengths and partnering to develop and test expanded DNA. In Stratos Genomics'DNA expansion process, four-nucleotide long probes (tetramer Xprobes) are sequentially ligated along a target DNA in a novel ligation process. A selectively cleavable bond connects the 2nd and 3rd nucleotides of the Xprobe. The two halves of each Xprobe are also connected via a long tether molecule. These tethers are user-defined molecules (e.g. DNA sections) that comprise reporters for encoding the four nucleotides of the Xprobe. Breaking of the cleavable bonds enables expansion of the polymer backbone. The resulting construct is called an Xpandomer. To date we have: (i) Demonstrated synthesis of the Xprobes; (ii) Demonstrated synthesis of Xpandomers;(without reporters) by the solution-based template-dependant extension of a primer using a novel ligation process; (iii) Demonstrated high ligation specificity and processivity; (iv) Fabricated very low noise solid-state SiNx nanopores; (v) Synthesized and measured high signal nanopore reporters with very low noise SiNx nanopores; (vi) Demonstrated Duplex Interrupt (DI) nanopore sequencing using the pore protein MspA (UofW); (vii) Sequenced DNA constructs mimicking expanded DNA in a MspA nanopore. The crucial steps in our project will be to optimize the DNA expansion process and to prove sequencing with the protein pore MspA and with solid-state nanopores. In parallel we will develop short (~17 base) DI-reporter sequences to be read in MspA and long (~100-base) reporters to be read in SiNx pores. Our two-year goal is to demonstrate conversion of 32-base DNA into Xpandomers and read them with MspA or solid-state nanopores. Specific aims: i) Survey and select optimal ligase for ligation of tetramer Xprobes, ii) Synthesize 32-base encoded Xpandomers with full library of tetramer DI-Xprobes, iii) Sequence 32-base encoded Xpandomers in an MspA nanopore, iv) Develop a 4-state reporter for solid-state Xprobes and v) Sequence 32-base encoded Xpandomer in a solid-state SiNx nanopore. PUBLIC HEALTH RELEVANCE: The goal of this project is to realize nanopore DNA sequencing. The new technology will lower the fully burdened cost of whole genome sequencing to less than $1000. Providing low cost genomic sequencing will have enduring impact on healthcare by providing an effective tool to identify, diagnose, and develop treatments for life threatening diseases, including cancer, heart disease, autoimmune disorders, diabetes, Alzheimer's, multiple sclerosis, and obesity. It will have a future impact by providing an individual with a lifetime roadmap of personalized diagnostic and therapeutic care.

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    R21
  • Administering IC
    HG
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    418768
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    172
  • Ed Inst. Type
  • Funding ICs
    NHGRI:418768\
  • Funding Mechanism
    Research Projects
  • Study Section
    ZHG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    STRATOS GENOMICS, INC.
  • Organization Department
  • Organization DUNS
    808217488
  • Organization City
    SEATTLE
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    981213300
  • Organization District
    UNITED STATES